Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Eric Singhi shared a post on LinkedIn:
“It’s always a pleasure to collaborate with my dear friend and colleague, Dr. Arthi Sridhar!
Check out our editorial in ASCO Daily News on the CHOICE-01 study. While Toripalimab shows promise as a first-line treatment for mNSCLC, the proliferation of ‘me-too’ anti-PD-(L)1 drugs highlights disparities in global access.
We strongly advocate for treatments that not only enhance efficacy and tolerability, but also reduce costs to ensure equitable cancer care for all.”
Source: Eric Singhi/LinkedIn
Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.
Arthi Sridhar is an Advanced Thoracic Oncology Fellow at Mayo Clinic Rochester, focusing on thoracic malignancies and aiming for an academic career in this field. She is also a Committee Member of the ASCO Trainee Council at the American Society of Clinical Oncology (ASCO).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023